Dr. Henao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
201 Cedar St SE
STE 800
Albuquerque, NM 87106
Education & Training
- Baylor College of MedicineFellowship, Vascular Surgery - Independent, 2004 - 2006
- Texas Tech University Health Sciences Center at LubbockResidency, Surgery, 1999 - 2004
- University of Texas Medical Branch School of MedicineClass of 1999
- University of Texas at Austin Dell Medical SchoolB.A., Biology, 1990 - 1995
Certifications & Licensure
- NM State Medical License 2006 - 2027
- SD State Medical License Active through 2025
- IA State Medical License 2021 - 2023
- NE State Medical License 2021 - 2022
- TX State Medical License 2004 - 2007
- American Board of Surgery Vascular Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Top Docs Albuquerque The Magazine, 2013-2015
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Tack Optimized Balloon Angioplasty (TOBA) Study Start of enrollment: 2012 Aug 01
- Lutonix DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries Start of enrollment: 2013 Jun 03
- ENDOvascular Interventions With AngioMAX: The ENDOMAX Trial Start of enrollment: 2013 Sep 24
- Join now to see all
Publications & Presentations
PubMed
- Female and male patients have similar outcomes after transcarotid artery revascularization in prospective trials.Justin A Smith, Jane M Chung, Peter A Schneider, Christopher J Kwolek, Frank R Arko
Journal of Vascular Surgery. 2024-01-01 - One-year safety and effectiveness of the Alto abdominal stent graft in the ELEVATE IDE trial.Sean P Lyden, D Christopher Metzger, Steve Henao, Sonya Noor, Andrew Barleben
Journal of Vascular Surgery. 2023-02-01 - 35 citationsPROMISE I: Early feasibility study of the LimFlow System for percutaneous deep vein arterialization in no-option chronic limb-threatening ischemia: 12-month results.Daniel G. Clair, Jihad Mustapha, Mehdi H. Shishehbor, Peter Schneider, Steve Henao
Journal of Vascular Surgery. 2021-05-18
Journal Articles
- An Innovation That's Saving LivesSteve Henao MD, Innovation: America's Journal of Technology Commercialization, 4/1/2014
- Serum amyloid A impairs endothelium-dependent vasorelaxation and increased superoxide anion production in porcine coronary arteriesHenao EA, Chai H, Lin PH, Lumsden AB, Yao Q, and Chen CJ, Proceedings of 39th annual meeting of the Association for Academic Surgery, 1/1/2006
- Join now to see all
Books/Book Chapters
Lectures
- Addressing Clinical Challenges with Peripheral AtherectomySunriver, OR - 1/1/2017
- Contemporary Real World Data on Ovation iX and Prime PerformanceNew Orleans, LA - 1/1/2017
- Trans-Carotid Arterial Revascularization: Why Go Trans-Femoral ever again?New Orleans, LA - 1/1/2017
- Join now to see all
Other
- Hemodynamic Assessment for Lower Extremity Intervention - Why, When, and HowHenao S, American College of Cardiology Perspectives & Analysis
1/26/2017 - EVAR with Ovation and NellixHenao S, Global Vascular Digest
1/1/2016 - Improving Procedural Predictability in EVARHenao S, Endovascular Today
1/1/2015 - Join now to see all
Press Mentions
- Game-Changing Technology: Cutting the Risk of Stroke in HalfApril 3rd, 2017
- TriVascular Technologies, Inc. Receives FDA Approval of the Ovation iX(TM) Abdominal Stent Graft SystemAugust 4th, 2015
- Heart Hospital Team Performs First-of-Its-Kind ProcedureJanuary 23rd, 2014
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Other Languages
- Spanish
External Links
- Ultrasound Guided Tibial Access Techniquehttps://www.youtube.com/watch?v=KW7tqMYihw4&list=PL4LU1kay4dVbNi9lZWweeH1NS2MYVjQYR
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: